These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2231611)

  • 21. The effects of bisaramil on experimental arrhythmias.
    Paróczai M; Kárpáti E; Solti F
    Pharmacol Res; 1990; 22(4):463-80. PubMed ID: 2402479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic activity of 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Takagi K
    Jpn J Pharmacol; 1974 Aug; 24(4):589-9. PubMed ID: 4455968
    [No Abstract]   [Full Text] [Related]  

  • 23. Antiarrhythmic activity of the hydrochloride of 1-methoxymethyl-2-(1-perhydroazepinyl)ethyl ester of 2-(n)-pentyloxycarbanilic acid.
    Gibala P; Sotníková R; Knezl V; Drímal J
    Arzneimittelforschung; 1987 Feb; 37(2):149-52. PubMed ID: 3580018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential antiarrhythmic agents. II. Effects of amide reversal and ortho-methylation on activity of procaine amide.
    Yung DK; Vohra MM; Chu I
    J Pharm Sci; 1970 Oct; 59(10):1405-9. PubMed ID: 5471943
    [No Abstract]   [Full Text] [Related]  

  • 25. [Synthesis and antiarrhythmic activity of some (erythro)-phenylpropanediolamine compounds].
    Ren Y; Hua WY; Peng SX; Zhu DY; Guo YL
    Yao Xue Xue Bao; 1997 Apr; 32(4):264-70. PubMed ID: 11499028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and structure-activity relationships of a new series of antiarrhythmic agents: 4,4-disubstituted hexahydro-3H-pyrido[1,2-c]pyrimidin-3-ones and related compounds.
    Chorvat RJ; Prodan KA; Adelstein GW; Rydzewski RM; McLaughlin KT; Stamm MH; Frederick LG; Schniepp HC; Stickney JL
    J Med Chem; 1985 Sep; 28(9):1285-91. PubMed ID: 4032431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New antiarrhythmic agents. 2. Amide alkyl alpha-amino xylidides.
    McMaster PD; Byrnes EW; Feldman HS; Takman BH; Tenthorey PA
    J Med Chem; 1979 Oct; 22(10):1177-82. PubMed ID: 513065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antiarrhythmic effects of crebanine].
    Yu ZP; Mu YS; Zhao ZX; Wang FC
    Zhongguo Zhong Yao Za Zhi; 1992 Nov; 17(11):685-7, 704. PubMed ID: 1301759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential antiarrhythmic agents. 3. 4-amino-N-(2-(substituted amino)ethyl)-2,6-dimethylbenzamides.
    Yung DK; Lo EK; Vohra MM
    J Pharm Sci; 1972 Dec; 61(12):1953-9. PubMed ID: 4638102
    [No Abstract]   [Full Text] [Related]  

  • 31. Antiarrhythmic activity of four pteridine compounds in ouabain intoxication.
    Yeh BK; Francis JS; Gosselin AJ; Elias RA
    Clin Pharmacol Ther; 1975 Feb; 17(2):141-5. PubMed ID: 235395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of new cyclopenteno[b]thiophene derivatives as local anesthetic and antiarrhythmic agents.
    al-Obaid AM; el-Subbagh HI; al-Shabanah OA; Mahran MA
    Pharmazie; 1998 Jan; 53(1):24-8. PubMed ID: 9476256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1974 Mar; 50(3):323-33. PubMed ID: 4850183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular charge associated with antiarrhythmic actions in a series of amino-2-cyclohexyl ester derivatives.
    Pugsley MK; Yong SL; Goldin AL; Hayes ES; Walker MJA
    Eur J Pharmacol; 2019 Feb; 844():241-252. PubMed ID: 30571955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic effect of the selective I1-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs.
    Mest HJ; Thomsen P; Raap A
    Ann N Y Acad Sci; 1995 Jul; 763():620-33. PubMed ID: 7677382
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental and initial clinical experiences with the new class Ib anti-arrhythmia agent barucainide].
    Gülker H; Heuer H; Frenking B; Haverkamp W; Hindricks G; Bozek B; Bremkes C; Asche KD; Witthöft D
    Z Kardiol; 1988 Sep; 77(9):587-94. PubMed ID: 2461620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New antiarrhythmic agents. 2,2,5,5-Tetramethyl-3-pyrroline-3-carboxamides and 2,2,5,5-tetramethylpyrrolidine-3-carboxamindes.
    Hankovszky OH; Hideg K; Bódi I; Frank L
    J Med Chem; 1986 Jul; 29(7):1138-52. PubMed ID: 3806567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The relationship between the chemical structure and the antiarrhythmic action of ethacizine and its analogs].
    Turilova AI; Berdiaev SIu; Grishchenko AN; Senova ZP
    Farmakol Toksikol; 1990; 53(6):20-1. PubMed ID: 2081560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New 5-aminoacyl-5,10-dihydro-11H-dibenzo[b,e][1,4]diazepin-11-ones with antiarrhythmic activity.
    Poppe H; Kaverina NV; Lyskovzev VV; Egerland U; Sauer W; Lichoscherstow A; Rüger C; Skoldinow A
    Pharmazie; 1997 Nov; 52(11):821-30. PubMed ID: 9399338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic activity of 3-amino-3-methyloxindoles.
    Kornet MJ; Thio PA; Malone N; Lubawy WC
    J Pharm Sci; 1975 Apr; 64(4):639-42. PubMed ID: 1142074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.